Award
National Institute of Allergy and Infectious Diseases 5R01AI124186-10
RNA-directed targeting of AID in immunity and cancer
Recipient
SLOAN-KETTERING INST CAN RESEARCH
Award Amount
$531,000.00
Ceiling
$531,000.00
Awarded
June 10, 2026
Identifier
5R01AI124186-10
Award for research on RNA-directed targeting of AID in immunity and cancer, funded by NIAID, conducted at Sloan-Kettering Institute in New York, with a value of $531,000.
Description
The project focuses on understanding the regulation of activation-induced cytidine deaminase (AID) and its role in immunity and cancer. The award is managed by the National Institute of Allergy and Infectious Diseases. The project is part of a multi-year funding cycle from 2026 to 2027. The project involves research at Sloan-Kettering Institute for Cancer Research in New York.